Quick Takeaways
- ACUT - Accustem Sciences Inc. has 6 insiders with reported activity on this page.
- Net insider value flow over the last year: +$20,902.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 6 Insiders of Accustem Sciences Inc.
- Symbol
- ACUT on OTC
- Location
- New York, NY
What Changed
- Buy value: $20,902; sell value: $0.
- Net share flow: +39,596.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$20,902.
Buys
$20,902
Shares: 39,596
Insiders: 1
Sells
$0
Shares: 0
Insiders: 0
Net
+$20,902
Shares: +39,596
Insiders: 1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 39,596 | 0 | $20,902 | $0 | +$20,902 |
Accustem Sciences Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Gabriele M. Cerrone | Director, 10%+ Owner | $7,152,640 | +$20,902 | +0.29% | Filing P/S | 13 Jun 2025 |
| Kunwar Shailubhai | Director | $14,175 | Mixed | 01 Dec 2021 | ||
| Wendy E. Blosser | Chief Executive Officer, Director | $2,800 | Mixed | 04 Mar 2022 | ||
| Willy Jules Simon | Director | $578 | Mixed | 01 Dec 2021 | ||
| John P. Brancaccio | Director | Mixed | 01 Dec 2021 | |||
| Keeren Shah | Chief Financial Officer | Mixed | 01 Dec 2021 |
Top shareholders of Accustem Sciences Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Gabriele M. Cerrone |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
6,502,400
|
$7,152,640 | +$20,902 | 13 Jun 2025 | |
| Kunwar Shailubhai |
3/4/5
|
Director |
—
class O/S missing
|
10,125
|
$14,175 | — | 01 Dec 2021 | |
| Wendy E. Blosser |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
2,000
|
$2,800 | — | 04 Mar 2022 | |
| Willy Jules Simon |
3/4/5
|
Director |
—
class O/S missing
|
413
|
$578 | — | 01 Dec 2021 |
Recent Insider Transactions by Companies or Individuals for Accustem Sciences Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Gabriele M. Cerrone | ACUT | Common Stock | Purchase | 0.04% | $2,440 | $1.02 | 2,400 | 6,502,400 | 13 Jun 2025 | Via Panetta Partners Limited |
| Gabriele M. Cerrone | ACUT | Common Stock | Purchase | 0.14% | $7,463 | $0.8300 | 8,991 | 6,500,000 | 12 Jun 2025 | Via Panetta Partners Limited |
| Gabriele M. Cerrone | ACUT | Common Stock | Purchase | 0.44% | $11,000 | $0.3900 | 28,205 | 6,491,009 | 11 Jun 2025 | Via Panetta Partners Limited |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.